Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-02-06

FDA Approved: FOSAMAX — Supplemental Application (Organon LLC)

View source ↗

Summary

The FDA approved a supplemental application for Fosamax (alendronate sodium) from Organon LLC, updating the drug's labeling and/or approved indications. This ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FOSAMAX (ALENDRONATE SODIUM)

Snippet

SUPPL AP for FOSAMAX (ALENDRONATE SODIUM)